-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US05330T2050 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Beta | nan |
|---|---|
| Market Cap | 5M |
| PE Ratio | None |
| Target Price | 18 |
| Dividend Yield | None |
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AMIX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025